97 related articles for article (PubMed ID: 24486110)
1. Effect of concurrent radiochemotherapy and chemotherapy on serum proteins for prospective predictors of patients with HPV induced cervical cancer.
Dasari S; Shouri RN; Rajendra W; Valluru L
Biomed Pharmacother; 2014 Apr; 68(3):315-20. PubMed ID: 24486110
[TBL] [Abstract][Full Text] [Related]
2. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
3. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy.
Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068
[TBL] [Abstract][Full Text] [Related]
4. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
[TBL] [Abstract][Full Text] [Related]
7. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
8. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
9. Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.
Trejo-Becerril C; Oñate-Ocaña LF; Taja-Chayeb L; Vanoye-Carlo A; Cetina L; Duenas-Gonzalez A
BMC Cancer; 2005 Jun; 5():65. PubMed ID: 15982417
[TBL] [Abstract][Full Text] [Related]
10. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy.
Braicu EI; Fotopoulou C; Chekerov R; Richter R; Blohmer J; Kümmel S; Stamatian F; Yalcinkaya I; Mentze M; Lichtenegger W; Sehouli J
Cytokine; 2013 Mar; 61(3):755-8. PubMed ID: 23415672
[TBL] [Abstract][Full Text] [Related]
11. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
12. Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer.
Nobeyama H; Sumi T; Misugi F; Okamoto E; Hattori K; Matsumoto Y; Yasui T; Honda K; Iwai K; Ishiko O
Int J Mol Med; 2004 Jul; 14(1):101-5. PubMed ID: 15202023
[TBL] [Abstract][Full Text] [Related]
13. IGF1R gene expression as a predictive marker of response to ionizing radiation for patients with locally advanced HPV16-positive cervical cancer.
Moreno-Acosta P; Gamboa O; Sanchez de Gomez M; Cendales R; Diaz GD; Romero A; Balart Serra J; Conrado Z; Levy A; Chargari C; Magné N
Anticancer Res; 2012 Oct; 32(10):4319-25. PubMed ID: 23060553
[TBL] [Abstract][Full Text] [Related]
14. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
15. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
[TBL] [Abstract][Full Text] [Related]
16. Serological study in Tunisian cervical cancer patients.
Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
[TBL] [Abstract][Full Text] [Related]
17. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
20. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
Lee YY; Choi CH; Kim CJ; Song TJ; Kim MK; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2010 Mar; 116(3):459-63. PubMed ID: 20004008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]